233 related articles for article (PubMed ID: 19222485)
21. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.
Halperin R; Zehavi S; Hadas E; Habler L; Bukovsky I; Schneider D
Int J Gynecol Cancer; 2003; 13(1):32-7. PubMed ID: 12631217
[TBL] [Abstract][Full Text] [Related]
22. Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer.
Akkour K; Alanazi IO; Alfadda AA; Masood A; Alhalal H; Joy SS; Bassi A; Alshehri E; Alwehaibi MA; Arafah M; Benabdelkamel H
BMC Cancer; 2024 Jun; 24(1):752. PubMed ID: 38902713
[TBL] [Abstract][Full Text] [Related]
23. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
[TBL] [Abstract][Full Text] [Related]
25. Construction of three-dimensional in vitro culture model of ovarian carcinoma and the study of its multicellular drug resistance.
Lu M; Gao R; Xiao L; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):741-3. PubMed ID: 17357506
[TBL] [Abstract][Full Text] [Related]
26. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
27. Quantitative Proteomic Analysis of 2D and 3D Cultured Colorectal Cancer Cells: Profiling of Tankyrase Inhibitor XAV939-Induced Proteome.
Kim YE; Jeon HJ; Kim D; Lee SY; Kim KY; Hong J; Maeng PJ; Kim KR; Kang D
Sci Rep; 2018 Sep; 8(1):13255. PubMed ID: 30185973
[TBL] [Abstract][Full Text] [Related]
28. Novel three-dimensional in vitro models of ovarian endometriosis.
Brueggmann D; Templeman C; Starzinski-Powitz A; Rao NP; Gayther SA; Lawrenson K
J Ovarian Res; 2014 Feb; 7():17. PubMed ID: 24502583
[TBL] [Abstract][Full Text] [Related]
29. Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.
Casagrande N; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Clin Cancer Res; 2014 Nov; 20(21):5496-506. PubMed ID: 25231401
[TBL] [Abstract][Full Text] [Related]
30. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Limonta P; Gagliano N
Cells; 2019 Feb; 8(2):. PubMed ID: 30754655
[TBL] [Abstract][Full Text] [Related]
32. Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer.
Chitcholtan K; Asselin E; Parent S; Sykes PH; Evans JJ
Exp Cell Res; 2013 Jan; 319(1):75-87. PubMed ID: 23022396
[TBL] [Abstract][Full Text] [Related]
33. Multicellular 3D Models to Study Tumour-Stroma Interactions.
Colombo E; Cattaneo MG
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562840
[TBL] [Abstract][Full Text] [Related]
34. [Non-small cell lung cancer 95D cells co-cultured with 3D-bioprinted scaffold to construct a lung cancer model in vitro].
Mou H; Wang J; Hu H; Xu W; Chen Q
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):736-40. PubMed ID: 26813591
[TBL] [Abstract][Full Text] [Related]
35. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
[TBL] [Abstract][Full Text] [Related]
36. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of serum CA125 levels with ER, PR, P53 and Ki-67 expression in endometrial carcinomas.
Budak E; Solakoglu Kahraman D; Budak A; Yanarateş A; Inan AH; Kanmaz AG; Beyan E
Ginekol Pol; 2019; 90(12):675-683. PubMed ID: 31909459
[TBL] [Abstract][Full Text] [Related]
38. Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).
Musrap N; Tuccitto A; Karagiannis GS; Saraon P; Batruch I; Diamandis EP
J Biol Chem; 2015 Jul; 290(28):17218-27. PubMed ID: 26004777
[TBL] [Abstract][Full Text] [Related]
39. Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer.
Kulawiec M; Arnouk H; Desouki MM; Kazim L; Still I; Singh KK
Cancer Biol Ther; 2006 Aug; 5(8):967-75. PubMed ID: 16775426
[TBL] [Abstract][Full Text] [Related]
40. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
